• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清CA19-9水平与糖尿病患者的代谢控制及胰岛β细胞功能相关。

Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients.

作者信息

Yu Haoyong, Li Ruixia, Zhang Lei, Chen Haibing, Bao Yuqian, Jia Weiping

机构信息

School of Medicine, Shanghai Jiao Tong University, Shanghai 200233, China.

出版信息

Exp Diabetes Res. 2012;2012:745189. doi: 10.1155/2012/745189. Epub 2012 Jun 12.

DOI:10.1155/2012/745189
PMID:22778715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3384953/
Abstract

CA19-9 is a tumor-associated antigen. It is also a marker of pancreatic tissue damage that might be caused by diabetes. Long-term poor glycemic control may lead to pancreatic beta cell dysfunction which is reflected by elevated serum CA19-9 level. Intracellular cholesterol accumulation leads to islet dysfunction and impaired insulin secretion which provide a new lipotoxic model. This study firstly found total cholesterol was one of the independent contributors to CA19-9. Elevated serum CA19-9 level in diabetic patients may indicate further investigations of glycemic control, pancreatic beta cell function, and total cholesterol level.

摘要

CA19-9是一种肿瘤相关抗原。它也是可能由糖尿病引起的胰腺组织损伤的标志物。长期血糖控制不佳可能导致胰腺β细胞功能障碍,这表现为血清CA19-9水平升高。细胞内胆固醇蓄积导致胰岛功能障碍和胰岛素分泌受损,这提供了一种新的脂毒性模型。本研究首次发现总胆固醇是CA19-9的独立影响因素之一。糖尿病患者血清CA19-9水平升高可能提示需要进一步检查血糖控制情况、胰腺β细胞功能和总胆固醇水平。

相似文献

1
Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients.血清CA19-9水平与糖尿病患者的代谢控制及胰岛β细胞功能相关。
Exp Diabetes Res. 2012;2012:745189. doi: 10.1155/2012/745189. Epub 2012 Jun 12.
2
Effect of glycotoxicity and lipotoxicity on carbohydrate antigen 19 - 9 in the patients with diabetes.糖毒性和脂毒性对糖尿病患者糖类抗原19-9的影响。
BMC Endocr Disord. 2024 Apr 24;24(1):51. doi: 10.1186/s12902-024-01578-5.
3
Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.糖尿病患者中检测胰腺癌的CA19-9建议临界值:一项病例对照研究
Endocr J. 2018 Jun 27;65(6):639-643. doi: 10.1507/endocrj.EJ17-0380. Epub 2018 Apr 11.
4
Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.胰岛素分泌、β细胞质量和胰岛血流灌注的早期缺陷先于 BioBreeding 大鼠自身免疫 1 型糖尿病的发病。
Diabetologia. 2018 Apr;61(4):896-905. doi: 10.1007/s00125-017-4512-z. Epub 2017 Dec 6.
5
The Correlated Factors of Serum CA19-9 Levels in Diabetic Patients.糖尿病患者血清CA19-9水平的相关因素
Curr Diabetes Rev. 2017;13(1):47-49. doi: 10.2174/1573399812666151012115546.
6
The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.二甲双胍对2型糖尿病患者血清糖类抗原19-9(CA 19-9)水平的影响
J Assoc Physicians India. 2018 Mar;66(3):38-41.
7
CA 19-9 is associated with poor glycemic control in diabetic patients: role of insulin resistance.糖类抗原19-9与糖尿病患者血糖控制不佳有关:胰岛素抵抗的作用。
Clin Lab. 2014;60(3):441-7. doi: 10.7754/clin.lab.2013.121243.
8
Restoring Mitochondrial Function: A Small Molecule-mediated Approach to Enhance Glucose Stimulated Insulin Secretion in Cholesterol Accumulated Pancreatic beta cells.恢复线粒体功能:一种小分子介导的方法,用于增强胆固醇积累的胰腺β细胞中葡萄糖刺激的胰岛素分泌。
Sci Rep. 2016 Jun 10;6:27513. doi: 10.1038/srep27513.
9
Type 2 diabetes mellitus and CA 19-9 levels.2型糖尿病与CA 19-9水平
World J Gastroenterol. 2007 Oct 28;13(40):5357-9. doi: 10.3748/wjg.v13.i40.5357.
10
Are diabetic metabolic compensation and CA19.9 really correlated?糖尿病代谢代偿与CA19.9真的相关吗?
Int J Biol Markers. 1996 Oct-Dec;11(4):207-10. doi: 10.1177/172460089601100405.

引用本文的文献

1
Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy.2型糖尿病患者降糖治疗后CA19-9水平变化及相关影响因素
Sci Rep. 2025 Jan 8;15(1):1264. doi: 10.1038/s41598-025-85807-4.
2
Sex-specific association between carbohydrate antigen 19-9 and incident type 2 diabetes.CA19-9 与 2 型糖尿病发病风险的性别特异性关联。
Sci Rep. 2024 Sep 28;14(1):22506. doi: 10.1038/s41598-024-73404-w.
3
Effect of glycotoxicity and lipotoxicity on carbohydrate antigen 19 - 9 in the patients with diabetes.糖毒性和脂毒性对糖尿病患者糖类抗原19-9的影响。
BMC Endocr Disord. 2024 Apr 24;24(1):51. doi: 10.1186/s12902-024-01578-5.
4
Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study.中国成年人循环中糖类抗原19-9水平与2型糖尿病肾病的关联:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Jan 31;17:467-477. doi: 10.2147/DMSO.S434972. eCollection 2024.
5
Pancreatic Cancer: An Exocrine Tumor With Endocrine Characteristics.胰腺癌:一种具有内分泌特征的外分泌肿瘤。
Ann Surg. 2024 Dec 1;280(6):e17-e25. doi: 10.1097/SLA.0000000000006168. Epub 2023 Dec 5.
6
Extraordinarily high serum CA 19-9 in setting of pancreatic necrosis and underlying pancreatic adenocarcinoma: a case report.胰腺坏死合并胰腺导管腺癌患者血清CA 19-9异常升高:一例报告
J Surg Case Rep. 2023 Oct 14;2023(10):rjad550. doi: 10.1093/jscr/rjad550. eCollection 2023 Oct.
7
The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults.健康成年人中碳水化合物抗原(CA)19-9 水平与低骨骼肌质量的关联。
Nutrients. 2023 Jul 30;15(15):3394. doi: 10.3390/nu15153394.
8
Clinical significance of tumor markers in patients with type 2 diabetes: a retrospective observational study.2型糖尿病患者肿瘤标志物的临床意义:一项回顾性观察研究。
Diabetol Int. 2022 Jul 12;14(1):40-50. doi: 10.1007/s13340-022-00594-x. eCollection 2023 Jan.
9
Correlation Between Blood Glucose Control and Levels of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Patients with Type-2 Diabetes Mellitus.2型糖尿病患者血糖控制与糖类抗原19-9及癌胚抗原水平的相关性
Diabetes Metab Syndr Obes. 2022 Aug 15;15:2489-2495. doi: 10.2147/DMSO.S370511. eCollection 2022.
10
High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control.血糖控制不佳的糖尿病住院患者癌胚抗原异常的高患病率。
Diabetes Metab Syndr Obes. 2022 Aug 4;15:2345-2352. doi: 10.2147/DMSO.S376024. eCollection 2022.

本文引用的文献

1
Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes?糖尿病中的外分泌性胰腺功能不全:糖尿病神经病变的一种并发症还是一种不同类型的糖尿病?
Exp Diabetes Res. 2011;2011:761950. doi: 10.1155/2011/761950. Epub 2011 Aug 1.
2
CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications.2 型糖尿病患者的 CA 19-9 水平及其与代谢控制和微血管并发症的关系。
Am J Med Sci. 2011 Jan;341(1):28-32. doi: 10.1097/MAJ.0b013e3181f0e2a0.
3
[Cholesterol metabolism and beta-cell function].[胆固醇代谢与β细胞功能]
Med Sci (Paris). 2010 Apr;26(4):385-90. doi: 10.1051/medsci/2010264385.
4
Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity.胰腺β细胞特异性SREBP-2转基因小鼠中的胆固醇积累与糖尿病:一种脂毒性新模型
J Lipid Res. 2008 Dec;49(12):2524-34. doi: 10.1194/jlr.M800238-JLR200. Epub 2008 Aug 5.
5
Type 2 diabetes mellitus and CA 19-9 levels.2型糖尿病与CA 19-9水平
World J Gastroenterol. 2007 Oct 28;13(40):5357-9. doi: 10.3748/wjg.v13.i40.5357.
6
Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction.胆固醇对胰岛素分泌的直接作用:胰腺β细胞功能障碍的一种新机制。
Diabetes. 2007 Sep;56(9):2328-38. doi: 10.2337/db07-0056. Epub 2007 Jun 15.
7
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.美国临床肿瘤学会(ASCO)2006年关于肿瘤标志物在胃肠道癌中应用的推荐更新
J Clin Oncol. 2006 Nov 20;24(33):5313-27. doi: 10.1200/JCO.2006.08.2644. Epub 2006 Oct 23.
8
INTERRELATIONSHIP OF DIABETES MELLITUS AND PANCREATITIS.糖尿病与胰腺炎的相互关系
Arch Surg. 1963 Nov;87:844-50. doi: 10.1001/archsurg.1963.01310170130022.
9
Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group.血糖控制不佳的糖尿病患者血清CA19-9水平升高。与Lewis血型的关系。
Gastroenterol Clin Biol. 1994;18(1):17-20.
10
Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis.弥漫性泛细支气管炎患者肿瘤相关碳水化合物抗原的升高。
Am Rev Respir Dis. 1993 Sep;148(3):744-51. doi: 10.1164/ajrccm/148.3.744.